In addition, there is an increase in the expression of VDAC1 in the PD cell model induced by rotenone [78], 1-methyl-4-phenylpyridinium (MPP+) [79], and 6-hydroxydopamine (6-OHDA) [80]. Here, VDAC1 is linked to Parkinson disease.